Combination of Atorvastatin with Sulindac or Naproxen Profoundly Inhibits Colonic Adenocarcinomas by Suppressing the p65/β-Catenin/Cyclin D1 Signaling Pathway in Rats

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Prevention Research

• Publication date

  2011-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1940-6207.CAPR-11-0222PMID 21764859PMCID PMC3208056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• International Trends in Colorectal Cancer Incidence Rates

  2009cited by this paper
• Chemopreventive Efficacy of Naproxen and Nitric Oxide–naproxen in Rodent Models of Colon, Urinary Bladder, and Mammary Cancers

  2009cited by this paper
• Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer

  2009cited by this paper
• Nuclear cyclin D1: An oncogenic driver in human cancer

  2009cited by this paper
• Colon cancer: preventive agents and the present status of chemoprevention

  2009cited by this paper
• Cytokines: from gut inflammation to colorectal cancer.

  2008cited by this paper
• Inflammation: gearing the journey to cancer.

  2008cited by this paper
• Wnt signalling and its impact on development and cancer

  2008cited by this paper
• The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

  2007cited by this paper
• Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer

  2007cited by this paper
• Strategies for colon cancer prevention: combination of chemopreventive agents.

  2007cited by this paper
• Pterostilbene, an Active Constituent of Blueberries, Suppresses Aberrant Crypt Foci Formation in the Azoxymethane-Induced Colon Carcinogenesis Model in Rats

  2007cited by this paper
• Nuclear factor-κB in cancer development and progression

  2006cited by this paper
• Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun.

  2006cited by this paper
• Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.

  2006cited by this paper
• Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

  2006cited by this paper
• Nitric oxide–releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets

  2006cited by this paper
• Celecoxib for the prevention of colorectal adenomatous polyps.

  2006cited by this paper
• Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.

  2006cited by this paper
• Suppressive effect of an inducible nitric oxide inhibitor, ONO-1714, on AOM-induced rat colon carcinogenesis.

  2006influential reference
• Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers.

  2006cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• Non‐steroidal anti‐inflammatory drugs for the prevention and treatment of cancer

  2005cited by this paper
• Convergence of Wnt, beta-catenin, and cadherin pathways.

  2004cited by this paper
• Convergence of Wnt, ß-Catenin, and Cadherin Pathways

  2004cited by this paper
• Nitric oxide signaling in colon cancer chemoprevention.

  2004cited by this paper
• Gene mutations and altered gene expression in azoxymethane‐induced colon carcinogenesis in rodents

  2004cited by this paper
• Caught up in a Wnt storm: Wnt signaling in cancer.

  2003cited by this paper
• Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.

  2002cited by this paper
• Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.

  2002cited by this paper
• Red wine and black tea polyphenols modulate the expression of cycloxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced f344 rat colon tumors.

  2002cited by this paper
• Role of nitric oxide in carcinogenesis and tumour progression.

  2001cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor.

  2000cited by this paper
• Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.

  2000cited by this paper
• Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.

  2000cited by this paper
• Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.

  1999cited by this paper
• Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

  1999cited by this paper
• Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.

  1999cited by this paper
• Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis.

  1998cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

  1998cited by this paper
• Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

  1997cited by this paper
• Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.

  1997cited by this paper
• Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.

  1997cited by this paper
• Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors.

  1996cited by this paper
• Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.

  1996cited by this paper
• Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.

  1996influential reference
• Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

  1995cited by this paper
• Cancer statistics

  1989cited by this paper
• Chemoprevention of Colon Carcinogenesis by Sulindac , a Nonsteroidal Anti-inflammatory Agent 1

  year unknowncited by this paper

• Role of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Prevention, Diagnosis, and Treatment of Gastrointestinal Cancers.

  2024cites this paper
• A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy.

  2024cites this paper
• Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review

  2024cites this paper
• The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer

  2023cites this paper
• Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies

  2023cites this paper
• Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects

  2023cites this paper
• Colorectal Cancer Chemoprevention: A Dream Coming True?

  2023cites this paper
• NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future.

  2021cites this paper
• Reexamining the role of tissue inflammation in radiation carcinogenesis: a hypothesis to explain an earlier onset of cancer

  2021cites this paper
• Combination of UPLC–Q-TOF/MS and Network Pharmacology to Reveal the Mechanism of Qizhen Decoction in the Treatment of Colon Cancer

  2021cites this paper
• Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice

  2021cites this paper
• Short-term aspirin and statin chemoprophylaxis did not reduce the risk of developing advanced adenomatous polyps in Black patients

  2021cites this paper
• Anticancer and Antimicrobial Activities of Naproxen and Naproxen Derivatives.

  2020cites this paper
• Integration of Genetic Variants and Gene Network for Drug Repurposing in Colorectal Cancer.

  2020cites this paper
• Chemoprevention of Colorectal Cancer.

  2020cites this paper
• Amino-alcohol Bio-conjugate of Naproxen Exhibits Anti-inflammatory Activity through NF-κB Signaling Pathway

  2020cites this paper
• A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

  2020cites this paper
• Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials

  2020cites this paper
• A comprehensive overview of colon cancer- a grim reaper of the 21st century.

  2020cites this paper
• Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.

  2020cites this paper
• The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies

  2020cites this paper
• Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma

  2019cites this paper
• Anti-tumor platinum (IV) complexes bearing the anti-inflammatory drug naproxen in the axial position

  2019cites this paper
• Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers

  2019cites this paper
• Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells

  2019cites this paper
• Statins and Colorectal Cancer - A Systematic Review.

  2018cites this paper
• T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection

  2018cites this paper
• Aspirin alone and combined with a statin suppresses eicosanoid formation in human colon tissue[S]

  2018cites this paper
• Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives

  2018cites this paper
• Production of nanostructured molecular liquids by supercritical CO2 processing

  2017cites this paper
• Drug repurposing in cancer.

  2017cites this paper
• Marketed drugs used for the management of hypercholesterolemia as anticancer armament

  2017cites this paper
• Naproxen Inhibits UVB‐induced Basal Cell and Squamous Cell Carcinoma Development in Ptch1+/−/SKH‐1 Hairless Mice

  2017cites this paper
• Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer

  2017cites this paper
• Differential preventive activity of sulindac and atorvastatin in Apc+/Min-FCCCmice with or without colorectal adenomas

  2017cites this paper
• Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis

  2017cites this paper
• Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.

  2016cites this paper
• Selective inhibition by aspirin and naproxen of mainstream cigarette smoke-induced genotoxicity and lung tumors in female mice

  2016cites this paper
• Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer

  2016cites this paper
• Statins in the chemoprevention of colorectal cancer in established animal models of sporadic and colitis-associated cancer

  2015cites this paper
• Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors

  2015cites this paper
• Modulation by aspirin and naproxen of nucleotide alterations and tumors in the lung of mice exposed to environmental cigarette smoke since birth.

  2015cites this paper
• Characterization of R-ketorolac as a single enantiomer selective inhibitor of Cdc42 and Rac1 in ovarian cancer

  2015cites this paper
• Successful Control of Liver Metastases From Pancreatic Solid-Pseudopapillary Neoplasm (SPN) Using Hepatic Arterial Embolization

  2015cites this paper
• Inflammatory Dysregulation and Cancer: From Molecular Mechanisms to Therapeutic Opportunities

  2015cites this paper
• Stress Response Pathways in Cancer

  2015cites this paper
• A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells

  2014cites this paper
• Cholesteryl-modified poly (monomethyl itaconate)s micelles as nano-carriers for pH-responsive drug delivery

  2014cites this paper
• Chemoprevention of Colorectal Cancer by Anti‐Inflammatory Agents

  2014cites this paper
• Chemopreventive drugs : Mechanisms via inhibition of cancer stem cells in colorectal cancer

  2014cites this paper
• Enhancing cubosome functionality by coating with a single layer of poly-ε-lysine.

  2014cites this paper
• The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer.

  2014cites this paper
• Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer.

  2014cites this paper
• The role of inflammation in colon cancer.

  2014cites this paper
• Statins in oncological research: from experimental studies to clinical practice.

  2014cites this paper
• [Statins and gastrointestinal cancers].

  2014cites this paper
• Statinok és az emésztőrendszeri daganatok

  2014cites this paper
• Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention

  2014cites this paper
• Chapter 2 The Role of Inflammation in Colon Cancer

  2014cites this paper
• Non-Steroidal Anti-Inflammatory Drugs Use Is Associated with Reduced Risk of Inflammation-Associated Cancers: NIH-AARP Study

  2014cites this paper
• Statins are associated with reduced risk of gastric cancer: A meta-analysis

  2013cites this paper
• PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Statins and Colorectal Cancer

  2013cites this paper
• Statins and colorectal cancer.

  2013cites this paper
• Synergistic induction of apoptosis by sulindac and simvastatin in A549 human lung cancer cells via reactive oxygen species-dependent mitochondrial dysfunction.

  2013cites this paper
• Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis.

  2013cites this paper
• Statins and colorectal cancer risk: a longitudinal study

  2013cites this paper
• Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.

  2013influential citation
• Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates

  2013cites this paper
• CN1 Statins and Colorectal Cancer: Is There a Link?

  2012cites this paper